Tag:
Budesonide
Latest Headlines
Latest Headlines
MAP shares slide after AZ dumps asthma pact
Shares of MAP Pharmaceuticals slid nine percent on the news that AstraZeneca had pulled out of a collaboration with the developer on an experimental pediatric asthma therapy, forcing MAP to suspend
MAP shares tumble after Phase III asthma failure
MAP Pharma's shares tanked on the news that its late-stage asthma therapy for children flunked a Phase III trial. Its stock swiftly plunged 40 percent in overnight trading as investors digested the
